Elisa Agostinetto: Our last meta-analysis led by Guilherme Nader Marta shows that ctDNA detection in early breast cancer is associated with higher risk of recurrence
Mar 15, 2024, 15:38

Elisa Agostinetto: Our last meta-analysis led by Guilherme Nader Marta shows that ctDNA detection in early breast cancer is associated with higher risk of recurrence

Elisa Agostinetto, Clinical Research Fellow at Jules Bordet Institute in Brussels, shared a post on X:

“Our last meta-analysis led by Guilherme Nader Marta shows that ctDNA detection in early breast cancer is associated with higher risk of recurrence, ctDNA detection had very high specificity for anticipating relapse.”

View the article.
Source: Elisa Agostinetto/X